Findings

What do systematic reviews say?

4,815 questions · 6,211 findings · 638 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,052 · 16.9%GRADE not reported 441 · 7.1%Very low 1,700 · 27.4%Low 1,651 · 26.6%Moderate 1,070 · 17.2%High 297 · 4.8%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Intervention not reported

Quality of life Not meta‐analysed · adults (> 18 years of age) with either COPD or recurrent acute exacerbations of chronic bronchitis

1 finding from 1 review

Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic… 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

SPRM vs leuprolide acetate

Adverse effects: SPRM‐associated endometrial changes · uterine fibroids

SPRM probably leads to higher adverse effects: SPRM‐associated endometrial changes compared with leuprolide acetate (moderate certainty).

1 finding from 1 review

Selective progesterone receptor modulators (SPRMs) for uterine fibroids 2017 · Cochrane Headline outcomes only
OR 10.45 [5.38, 20.33]
1 study · 301 participants
Moderate

SPRM vs placebo

Adverse effects: SPRM‐associated endometrial changes · women with uterine fibroids

SPRM may leads to higher adverse effects: SPRM‐associated endometrial changes compared with placebo (low certainty).

1 finding from 1 review

Selective progesterone receptor modulators (SPRMs) for uterine fibroids 2017 · Cochrane Headline outcomes only
OR 15.12 [6.45, 35.47]
5 studies · 405 participants
Low

Beta‐blockers vs placebo, no treatment or surveillance only

Aortic root diameter > 6 cm · people with confirmed diagnosis of Marfan syndrome

Beta‐blockers showed no clear difference in aortic root diameter > 6 cm compared with placebo, no treatment or surveillance only (low certainty).

1 finding from 1 review

Beta‐blockers for preventing aortic dissection in Marfan syndrome 2017 · Cochrane Headline outcomes only
RR 1.19 [0.08, 18.24]
1 study · 70 participants
Low

Intervention not reported

Gait: Comfortable Gait Speed (CGS) Gait measured over 7 metres (3 repetitions; average time calculated) Baseline and post‐intervention · adults with stroke

1 finding from 1 review

Yoga for stroke rehabilitation 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Very low

ICS dose reduction vs no change

FEV1 (L) · adults with asthma

1 finding from 1 review

Stepping down the dose of inhaled corticosteroids for adults with asthma 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 261 participants
Low

Antibiotic prophylaxis vs no treatment

Incidence of puerperal infection (endometritis) · women with episiotomy repair following vaginal birth

1 finding from 1 review

Antibiotic prophylaxis for episiotomy repair following vaginal birth 2017 · Cochrane Headline outcomes only
no estimate extracted
73 participants
Very low

Antibiotic prophylaxis vs no treatment or placebo

Endometritis · Women who had normal vaginal births

It is very uncertain whether routine antibiotic prophylaxis changes endometritis compared with no treatment or placebo (very low certainty).

1 finding from 1 review

Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity 2017 · Cochrane Headline outcomes only
RR 0.28 [0.09, 0.83]
2 studies · 1364 participants
Very low

Airway bypass stents vs control

Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 350 participants
High

Airway bypass stents vs control

Six‐minute walk distance · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 350 participants
Moderate

Endobronchial coils vs control

Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 461 participants
High

Endobronchial coils vs control

Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 461 participants
Low

Endobronchial valves vs control

Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 200 participants
Moderate

Endobronchial valves vs control

Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 379 participants
Low

Intrabronchial valves vs control

Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 312 participants
High

Intrabronchial valves vs control

Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 316 participants
Moderate

Vapour ablation vs control

Lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 69 participants
Moderate

AeriSeal vs control

Change from baseline in lung function parameters other than FEV1 · patients with chronic obstructive pulmonary disease

The review found no eligible studies for this question.

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vapour ablation vs control

Meters at end of · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 69 participants
Low

AeriSeal vs control

Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low